Las Vegas—With patients paying an increasing share of drug costs because of high-deductible plans and coinsurance replacing fixed, lower copays, the demand for financial assistance is increasing—and policymakers and payors are noticing, experts noted during several sessions at the 2018 Asembia Specialty Pharmacy Summit.
Between 2013 and 2017, co-pays dropped from 54% to 44% of patient costs, while the proportion paid by coinsurance rose from 24% to 29% and deductibles